PPARG and type 2 diabetes mellitus: This multi-tiered experimental strategy employing state-of-the-art biochemical, genetic, and in vivo approaches can be designed to rigorously test the novel hypothesis that thiamine is a functional PPARγ activator with therapeutic relevance to T2D.